Drug intelligence / Profile preview

PYY 3-36 nasal spray

Development stage
Unknown
Lead developer
MDRNA
Modality
Peptides, Small Molecules
Administration
Intranasal
01

Overview

PYY 3-36 nasal spray is a synthetic formulation of the human gut hormone peptide YY (fragment 3–36), delivered via the intranasal route. Peptide YY (PYY) is a naturally occurring hormone released postprandially from L-cells in the gastrointestinal tract and acts as a physiological inhibitor of food intake by promoting satiety. The mechanism of action involves agonism at neuropeptide Y receptor type 2 (Y2R), primarily in the hypothalamic arcuate nucleus, leading to reduced neuropeptide Y release and appetite suppression. The drug was developed as a non-invasive treatment for obesity, aiming to reduce body weight by decreasing caloric intake through enhanced satiety signaling[1][2][4]. Clinical trials have shown that while intranasal administration is generally safe and well-tolerated at lower doses, higher doses are associated with significant nausea and vomiting. Efficacy data indicate that this formulation did not achieve clinically meaningful weight loss compared to placebo over periods up to 24 weeks[1][2][4].

Other names
peptide YY(3-36) nasal sprayintranasal PYY(3-36)
02

Targets

NPY1R (Neuropeptide Y receptor Y1)NPY2R (Neuropeptide Y receptor subtype 2)

Beyond the preview

Go deeper on PYY 3-36 nasal spray.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PYY 3-36 nasal spray.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call